Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2)

K-Number: K231222 · 2023-10-30

ApplicantTopcon Corporation
Decision Date2023-10-30
Product CodeOBO
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2) is the device name listed in this FDA 510(k) record. The listed applicant is Topcon Corporation. It received FDA 510(k) clearance on 2023-10-30 under 510(k) number K231222. The device is classified under product code OBO. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2)?

3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2) is a medical device that received FDA 510(k) clearance on 2023-10-30. The listed applicant is Topcon Corporation. The 510(k) number is K231222.

When did 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2) receive FDA 510(k) clearance?

3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2) received FDA 510(k) clearance on 2023-10-30, under 510(k) number K231222.

Who is the listed applicant for 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2)?

The FDA 510(k) record lists Topcon Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2)?

The FDA product code for 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1(type: Maestro2) is OBO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT02270359Research on Infarction With Open Arteries Using OCT and CMRACTIVE_NOT_RECRUITINGNCT02710916SD-OCT Multimodal Analysis in GLaucomaCOMPLETEDNCT04465669Heterogeneity of Neointimal Healing Following Biodegradable-polymer Drug-Eluting Coronary Stent ImplantationCOMPLETEDNCT04772911Multicenter Phenotype-Genotype Analysis of Vascular Stains to Optimize Treatment Utilizing Optical Coherence TomographyACTIVE_NOT_RECRUITINGNCT04995341Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)RECRUITINGNCT05027984Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACSACTIVE_NOT_RECRUITING

Other records listing Topcon Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253039AUTO KERATO-REFRACTO TONOMETER TRK-3 OMNIAK2410813D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2); IMAGEnet6 Ophthalmic Data SystemK2335613D Optical Coherence Tomography (3D OCT-1(type: Maestro2))K232828IMAGEnet6 Ophthalmic Data SystemK221111Non-Mydriatic Retinal Camera NW500K173119DRI OCT Triton

View all 11 devices →

Related Devices (Code: OBO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253837SPECTRALIS HRA+OCT and variants; SPECTRALIS with Flex ModuleHeidelberg Engineering GmbHK252633UNITY DX (UDX)Cylite Pty. , Ltd.K250553Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey CorporationK250868SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbHK240924AnterionHeidelberg Engineering GmbHK241163SPECTRALIS with Flex ModuleHeidelberg Engineering GmbH

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑